Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

2 results

  • 30 - Neuropsychological Assessment of Dementia

  • from Part III - Assessment and Diagnosis of Specific Mental Disorders
  • Edited by Martin Sellbom, University of Otago, New Zealand, Julie A. Suhr, Ohio University
  • Book:
    The Cambridge Handbook of Clinical Assessment and Diagnosis
    Published online:
    06 December 2019
    Print publication:
    19 December 2019, pp 416-430

  • Summary

    Neuropsychological assessment plays an important role in detecting and characterizing the dementia syndrome associated with neurodegenerative diseases such as Alzheimer’s disease (AD). Comprehensive cognitive testing can identify mild cognitive deficits that typically occur in early stages of AD and can detect subtle cognitive changes that occur in the preclinical or prodromal stages of the disease before the onset of frank dementia. Recent evidence suggests that profiles of AD-related cognitive deficits may differ across cultures, perhaps due to incomplete or inappropriate adaptation of tests, distinct health factors (e.g., high vascular risk) that may impact cognition, or differences in normative data arising from education or health disparities. Neuropsychological assessment can also aid in differential diagnosis by identifying distinct cognitive profiles associated with AD and other neurodegenerative disorders that engender different distributions of brain pathology. These comparisons provide a useful method for understanding brain-behavior relationships that mediate the affected cognitive abilities.